Literature DB >> 7968257

The role of anergy in peripheral T cell unresponsiveness.

J G Johnson1, M K Jenkins.   

Abstract

When a T cell's encounter with specific antigen results in good signaling through the T cell antigen receptor yet does not lead to a proliferative response, the T cell enters a state of nonresponsiveness, or anergy. Anergy induction can result from a number of different situations, including antigen presentation by costimulation-deficient or "non-professional" antigen presenting cells, pharmacological blocking of T cell proliferation, or chronic stimulation of the T cell receptor by antigen. Anergy is a long-lived but temporary state characterized by a profound inability of the T cell to produce IL-2. Other effector functions may be affected to variable degrees. Anergy has been characterized most carefully under in vitro conditions, but several experimental models have demonstrated that T cells can also become anergic in vivo. This mechanism for tolerance induction may help to ensure that any mature autoreactive T cells which escape thymic deletion are unable to respond to host tissues. Furthermore, an understanding of the mechanism of anergy induction will most certainly lead to beneficial clinical applications, including improving graft acceptance and avoiding such deleterious immune responses as autoimmunity and allergy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7968257     DOI: 10.1016/0024-3205(94)90087-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro.

Authors:  H M Diepolder; M C Jung; E Wierenga; R M Hoffmann; R Zachoval; T J Gerlach; S Scholz; G Heavner; G Riethmüller; G R Pape
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 2.  Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes.

Authors:  L C Harrison
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

3.  T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro.

Authors:  P G Steenbakkers; A M Boots; A W Rijnders
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

4.  Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type.

Authors:  C Schoenbein; W-D Docke; K Wolk; G Belbe; C Hoflich; M Jung; G Grutz; W Sterry; H-D Volk; K Asadullah; R Sabat
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

Review 5.  Contribution of MicroRNAs to autoimmune diseases.

Authors:  Lucien P Garo; Gopal Murugaiyan
Journal:  Cell Mol Life Sci       Date:  2016-03-04       Impact factor: 9.261

6.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

Review 7.  Therapeutic use of Aldara in chronic myeloid leukemia.

Authors:  Annette M Marleau; Jeffrey H Lipton; Neil H Riordan; Thomas E Ichim
Journal:  J Transl Med       Date:  2007-01-25       Impact factor: 5.531

8.  Immune deviation of 2C transgenic intraepithelial lymphocytes in antigen-bearing hosts.

Authors:  S R Guehler; J A Bluestone; T A Barrett
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

9.  Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2.

Authors:  Yu Mi Oh; Hyung Bae Park; Jae Hun Shin; Ji Eun Lee; Ha Young Park; Dhong Hyo Kho; Jun Sung Lee; Heonsik Choi; Tomohiko Okuda; Koichi Kokame; Toshiyuki Miyata; In-Hoo Kim; Seung Hoon Lee; Ronald H Schwartz; Kyungho Choi
Journal:  Nat Commun       Date:  2015-10-28       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.